BN-101A (Scripps Korea Antibody Institute)

N/A

Report date: 2024/11/15 09:59:57

Base Information

Drug NameBN-101A (Scripps Korea Antibody Institute)
Drug Alias NamePD-L1 checkpoint inhibitor(Bioeleven)PD-L1 checkpoint inhibitor (Bioeleven)anti-PD-L1 antibody(Scripps Korea Antibody Institute)KL-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScripps Korea Antibody Institute
China Registration ClassN/A

Develop Information

Active CompaniesBio Eleven Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A